Rexahn Pharma (RNN) Commences RX-3117 Phase 1b/2a Stage 2 in r/r Metastatic Pancreatic Cancer
Go back to Rexahn Pharma (RNN) Commences RX-3117 Phase 1b/2a Stage 2 in r/r Metastatic Pancreatic Cancer| REXAHN PHARMACEUTICALS, Inc. (NYSE: RNN) | Delayed: 5.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.24 | 52 Week High | $0.48 | |||
| Open | $0.06 | 52 Week Low | $0.14 | |||
| Day High | $5.24 | P/E | N/A | |||
| Day Low | $5.24 | EPS | $-0.06 | |||
| Volume | 113,309 | |||||
